Net income
570 thousand USD
2022-07-01 – 2023-06-30
72 filing records in this dataset, filed from 2009-03-30 to 2023-08-21. Reported financial figures are available; chart coverage varies by period.
5000 USD
32132907 shares
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
570 thousand USD
2022-07-01 – 2023-06-30
-706 thousand USD
2022-01-01 – 2022-12-31
3 thousand USD
2017-01-01 – 2017-12-31
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2023-08-21.
Financial data available through: 2022-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 2.7 million
–
Current period
−USD 1.02 million
–
-1020000 − 2698000 = -3718000 USD
2698000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source-1020000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 693,000
–
Current period
−USD 706,000
–
-706000 − -693000 = -13000 USD
-693000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source-706000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value | Source evidence |
|---|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|
Cash generated by the company’s normal business operations.
| Period | Series | Value | Source evidence |
|---|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2013 2013-01-01 – 2013-12-31 | −USD 5.3 million Exact valueExact value: -5302000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.71 million Exact valueExact value: -4707000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 8,000 Exact valueExact value: 8000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.72 million Calculation and evidence-4707000 − 8000 USD Exact free cash flow: -4715000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2014 2014-01-01 – 2014-12-31 | −USD 6.99 million Exact valueExact value: -6994000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.04 million Exact valueExact value: -5044000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4,000 Exact valueExact value: 4000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.05 million Calculation and evidence-5044000 − 4000 USD Exact free cash flow: -5048000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2015 2015-01-01 – 2015-12-31 | −USD 5.89 million Exact valueExact value: -5886000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.63 million Exact valueExact value: -4633000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4,000 Exact valueExact value: 4000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.64 million Calculation and evidence-4633000 − 4000 USD Exact free cash flow: -4637000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2016 2016-01-01 – 2016-12-31 | −USD 3.19 million Exact valueExact value: -3187000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.73 million Exact valueExact value: -2733000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4,000 Exact valueExact value: 4000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.74 million Calculation and evidence-2733000 − 4000 USD Exact free cash flow: -2737000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2017 2017-01-01 – 2017-12-31 | −USD 11.1 million Exact valueExact value: -11100000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.09 million Exact valueExact value: -1092000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3,000 Exact valueExact value: 3000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.1 million Calculation and evidence-1092000 − 3000 USD Exact free cash flow: -1095000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2018-01-01 – 2018-12-31 | −USD 12,000 Exact valueExact value: -12000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 204,000 Exact valueExact value: -204000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −USD 934,000 Exact valueExact value: -934000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 313,000 Exact valueExact value: -313000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 6.3 million Exact valueExact value: -6295000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 374,000 Exact valueExact value: -374000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | USD 2.7 million Exact valueExact value: 2698000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 693,000 Exact valueExact value: -693000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 1.02 million Exact valueExact value: -1020000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 706,000 Exact valueExact value: -706000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
72 filings · 2,478 latest values · 2,478 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001421204, 1421204, GNSZ, NSPX, edgar:1421204
Also known as GENSPERA INC, INSPYR THERAPEUTICS, INC., Inspyr Therapeutics, Inc., REBUS HOLDINGS INC., REBUS HOLDINGS, INC., Rebus Holdings, Inc.